Shalby Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
October 27, 2023 at 03:04 am
Share
Shalby Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 2,379.84 million compared to INR 2,017.97 million a year ago. Revenue was INR 2,433.68 million compared to INR 2,071.03 million a year ago. Net income was INR 275.83 million compared to INR 184.11 million a year ago. Basic earnings per share from continuing operations was INR 2.57 compared to INR 1.71 a year ago. Diluted earnings per share from continuing operations was INR 2.57 compared to INR 1.7 a year ago.
For the six months, sales was INR 4,734.69 million compared to INR 4,034.78 million a year ago. Revenue was INR 4,833.87 million compared to INR 4,127.77 million a year ago. Net income was INR 484.09 million compared to INR 385.16 million a year ago. Basic earnings per share from continuing operations was INR 4.51 compared to INR 3.59 a year ago. Diluted earnings per share from continuing operations was INR 4.51 compared to INR 3.59 a year ago.
Shalby Limited is an India-based company, which operates multi-specialty hospital chains. The Company operate through three main verticals: hospital business, Shalby Orthopedics Centre of Excellence (SOCE) franchise and implant business. The Company is engaged in the arthroplasty segment. It has its presence across tertiary and quaternary specialties including cardiology, neurology, oncology and cardiac. SOCE offers a comprehensive orthopedic center with easy access and treatment for all orthopedic-related issues, including joint replacement surgery, at affordable rates. The Company encompasses a range of specialties, which include joint replacement surgery, critical care and trauma, spine surgery, neurology, and neurosurgery, ortho-oncology, cardiology and minimally invasive cardiac surgery, sports injury, kidney transplant, liver transplant, hepato-biliary surgery, pediatrics, medical oncology and once-surgery, dental cosmetics and implantology, ophthalmology, plastic and more.
SHALBY LIMITED 
